Livzon Pharmaceutical Group Inc (000513) — Financial Flexibility Index
Livzon Pharmaceutical Group Inc (000513) has a Financial Flexibility Index of 0.09x as of December 2025. Free cash flow of CN¥704.42 Million (operating CF CN¥625.70 Million minus capex CN¥78.72 Million) represents 0% of total liabilities (CN¥8.20 Billion). Check Livzon Pharmaceutical Group Inc (000513) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Livzon Pharmaceutical Group Inc Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Livzon Pharmaceutical Group Inc across 28 annual periods. See working capital position of Livzon Pharmaceutical Group Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Livzon Pharmaceutical Group Inc (1998–2025)
Year-by-year free cash flow to debt coverage for Livzon Pharmaceutical Group Inc. For the full company profile including market capitalisation, see market value of Livzon Pharmaceutical Group Inc.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥3.75 Billion | CN¥3.18 Billion | CN¥8.20 Billion | ▲ +23.2% |
| 2024 | 0.37x | CN¥3.55 Billion | CN¥2.98 Billion | CN¥9.55 Billion | ▼ -6.1% |
| 2023 | 0.40x | CN¥4.07 Billion | CN¥3.25 Billion | CN¥10.28 Billion | ▲ +5.9% |
| 2022 | 0.37x | CN¥3.71 Billion | CN¥2.77 Billion | CN¥9.93 Billion | ▼ -6.2% |
| 2021 | 0.40x | CN¥3.21 Billion | CN¥1.90 Billion | CN¥8.06 Billion | ▼ -1.4% |
| 2020 | 0.40x | CN¥2.81 Billion | CN¥2.16 Billion | CN¥6.95 Billion | ▲ +6.4% |
| 2019 | 0.38x | CN¥2.17 Billion | CN¥1.77 Billion | CN¥5.70 Billion | ▲ +24.0% |
| 2018 | 0.31x | CN¥1.74 Billion | CN¥1.27 Billion | CN¥5.69 Billion | ▼ -11.3% |
| 2017 | 0.35x | CN¥1.61 Billion | CN¥1.32 Billion | CN¥4.66 Billion | ▼ -28.3% |
| 2016 | 0.48x | CN¥1.65 Billion | CN¥1.28 Billion | CN¥3.42 Billion | ▲ +11.9% |
| 2015 | 0.43x | CN¥1.40 Billion | CN¥927.79 Million | CN¥3.27 Billion | ▲ +0.1% |
| 2014 | 0.43x | CN¥1.38 Billion | CN¥717.39 Million | CN¥3.22 Billion | ▼ -6.5% |
| 2013 | 0.46x | CN¥1.36 Billion | CN¥439.99 Million | CN¥2.96 Billion | ▼ -16.9% |
| 2012 | 0.55x | CN¥1.36 Billion | CN¥593.96 Million | CN¥2.45 Billion | ▼ -16.8% |
| 2011 | 0.66x | CN¥1.06 Billion | CN¥708.20 Million | CN¥1.59 Billion | ▼ -30.0% |
| 2010 | 0.95x | CN¥970.25 Million | CN¥633.30 Million | CN¥1.02 Billion | ▲ +36.2% |
| 2009 | 0.70x | CN¥626.29 Million | CN¥494.88 Million | CN¥898.92 Million | ▲ +80.4% |
| 2008 | 0.39x | CN¥420.70 Million | CN¥345.18 Million | CN¥1.09 Billion | ▲ +8.5% |
| 2007 | 0.36x | CN¥339.83 Million | CN¥248.55 Million | CN¥954.80 Million | ▼ -5.8% |
| 2006 | 0.38x | CN¥406.91 Million | CN¥226.46 Million | CN¥1.08 Billion | ▼ -16.3% |
| 2005 | 0.45x | CN¥417.79 Million | CN¥161.07 Million | CN¥925.20 Million | ▲ +41.8% |
| 2004 | 0.32x | CN¥327.94 Million | CN¥181.46 Million | CN¥1.03 Billion | ▼ -24.7% |
| 2003 | 0.42x | CN¥403.57 Million | CN¥300.01 Million | CN¥954.70 Million | ▼ -3.1% |
| 2002 | 0.44x | CN¥317.27 Million | CN¥213.65 Million | CN¥727.05 Million | ▲ +17.9% |
| 2001 | 0.37x | CN¥236.63 Million | CN¥155.15 Million | CN¥639.37 Million | ▲ +115.1% |
| 2000 | 0.17x | CN¥100.01 Million | CN¥38.52 Million | CN¥581.24 Million | ▼ -68.6% |
| 1999 | 0.55x | CN¥319.67 Million | CN¥246.23 Million | CN¥583.95 Million | ▲ +1792.1% |
| 1998 | 0.03x | CN¥13.53 Million | CN¥-18.21 Million | CN¥467.61 Million | — |